Aflibercept rch
About Bowel Cancer Targeted-Therapies-Zaltrap-770
 
At what stage is this treatment used?
 
  • Aflibercept (Zaltrap®) is a type of targeted drug known as a fusion protein.  This drug is designed to target multiple growth factors involved in cancer and angiogenesis, specifically proteins called VEGF-A, VEGF-B and a related protein called placental growth factor (PlGF).  Aflibercept is approved for use as treatment in second-line therapy in combination with chemotherapy (FOLFIRI) for advanced (metastatic) colorectal cancer.  
Treatment Zaltrap
 
Is this drug available via the Pharmaceutical Benefits Scheme (PBS) as a subsidised treatment?

  • Aflibercept is not currently listed on the PBS as a subsidised treatment.

Download the Consumer Medicine Information (CMI) for Zaltrap
 
Banner Bowel Cancer Australia Helpline
Support Bowel Cancer Australia
Bowel Cancer Australia Nutrition Lifestyle Challenge
Bowel cancer Australia Research
Bowel Cancer Australia Bowel Cancer App
Banner Bowel Cancer Australia Big Bowel
Bowel Cancer Australia Social Media
Banner Bowel Cancer Australia Screening Surveillance 300
Banner Bowel Cancer Australia Non Modifiable Risk Factors 300
Banner Bowel Cancer Australia Modifiable Risk Factors 300
BowelCancerAwarenessMonth 2016 300x600 Ribbon
Bowel Cancer Australia BowelScreen Australia Test
Bowel Cancer Australia Shop